JPAD-Journal of Prevention of Alzheimers Disease

Article	Citations
Association of Cognitive Reserve Indicator with Cognitive Decline and Structural Brain Differences in Middle and Older Age: Findings from the UK Biobank	390
“Back to Braak”: Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression	207
Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid	196
The Scottish Brain Health Service Model: Rationale and Scientific Basis for a National Care Pathway of Brain Health Services in Scotland	194
The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging	87
Mendelian Randomization Analysis to Assess Whether Magnetic Resonance Imaging Signs of Cerebral Small Vessel Disease Can Cause Cognitive Decline and Dementia	71
Blood Cathepsins on the Risk of Alzheimer's Disease and Related Pathological Biomarkers: Results from Observational Cohort and Mendelian Randomization Study	61
The Relationship between History of Traumatic Brain Injury and Longitudinal Changes in Cortical Thickness among Patients with Alzheimer's Disease	46
Neuroprotective Effects of IVIG against Alzheimer's Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice	44
Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial	41
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease	36
Effectiveness of Resistance Exercise on Cognitive Function in Animal Models of Alzheimer Disease: A Systematic Review and Meta-Analysis	35
Estimating Socio-Economic Status for Alzheimer's Disease Trials	31
Meta Analysis of the Correlation between Periodontal Health and Cognitive Impairment in the Older Population	29
Associations of Blood Pressure Trajectories with Subsequent Cognitive Decline, Dementia and Mortality	29
Cognitive Performance and Incident Alzheimer's Dementia in Men Versus Women	26
Maximizing the Utility of Alzheimer's Disease Trial Data: Sharing of Baseline A4 and LEARN Data	23
Preferences about Future Alzheimer's Disease Treatments Elicited through an Online Survey Using the Threshold Technique	22
The Geras Solutions Cognitive Test for Assessing Cognitive Impairment: Normative Data from a Population-Based Cohort	22
Opportunities for Cellular Rejuvenation in Alzheimer's Disease: How Epigenetic Reprogramming and Chaperone-Mediated Autophagy Are Enabling Next Generation Therapeutic Approaches	21
Multidomain Intervention for the Reversal of Cognitive Frailty Using a Personalized Approach (AGELESS Trial): Recruitment and Baseline Characteristics of Participants	21
Update to: Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease	20
Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of “Time Saved”	19
Universal Prevention of Dementia in Italy: A Document Analysis of the 21 Italian Regional Prevention Plans	19
Validation of the CogDrisk Instrument as Predictive of Dementia in Four General Community-Dwelling Populations	18

Medical Costs and Caregiver Burden of Delivering Disease-Modifying Alzheimer's Treatments with Different Duration and Route of Administration	17
Heightened Prevalence of Common Hospital-Treated Infections Preceding Dementia Diagnosis with Accelerated Dementia Onset after Influenza	17
Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study	16
Progress in the Treatment of Alzheimer's Disease Is Needed – Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators	16
Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort	16
Corrigendum to “Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study” [The Journal of Prevention of Alzheimer's Disease 2024;11(3):567	15
Vision, courage, and academic freedom	14
Editorial Board	13
Erratum to: Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats	13
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research	13
The associations between fresh vegetable and fruit consumption and plasma and PET biomarkers in preclinical Alzheimer's disease: A cross-sectional and longitudinal study of Chinese population	12
American's overall and equity-based societal valuation of a disease-modifying Alzheimer's treatment: Results from a discrete choice experiment	12
Multisensory stimulation reduces neuropsychiatric symptoms and enhances cognitive function in older adults with dementia: A meta-analysis of randomized controlled trials	11
Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease	11
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population	11
Longitudinal associations of carotid artery stiffness with progression of cerebrovascular disease, incident dementia and cognitive decline in older adults	11
Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort study: Methods, Baseline and Longitudinal Results of the A3C Study	11
Maintaining level of modifiable dementia risk scores is associated with better cognitive outcomes than increasing risk scores: A population-based prospective cohort study	10
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease	10
Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials	10
Association of statins use and genetic susceptibility with incidence of Alzheimer's disease	10
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217	10
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation	10
Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment	10
Patient management pathways in dementia – Resource utilisation, diagnosis and drug treatment in the Stockholm region, Sweden	9
Multi-omics analysis of druggable genes to facilitate Alzheimer's disease therapy: A multi-cohort machine learning study	9
Editorial Board	9
The US Expert Panel on the Appropriate Use Recommendations of Aducanumab in Clinical Practice	9
Dietary patterns and blood-based biomarkers of Alzheimer's disease in cognitively intact older adults: Findings from a population-based study	9
A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease	9
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease	9
The Clinical Trials Alzheimer's Disease (CTAD) Meeting in San Francisco, Fall 2022, Will Be a Very Exciting Event!	8
Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and Treatment	8
Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease	8
Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia	8
Alzheimer's Disease Prevention Health Coaching	8
Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials	8
Ten Years after the National Alzheimer's Plan: Dementia Remains a Hidden Syndrome in France	8
Relationships of Hypnotics with Incident Dementia and Alzheimer's Disease: A Longitudinal Study and Meta-Analysis	7
Expanding the ATN Framework to Further Personalize Therapies	7
Genetically Determined Alzheimer's Disease Is Associated with Increased Risk of Varicose Vein: A Mendelian Randomization Study	7
Dietary Cholesterol and Dementia Risk	7
Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults	7
Investigating the Impact of Tea Consumption on Cognitive Function and Exploring Tea-Genetic Interactions in Older Adults Aged 65–105 Years: Findings from the 2002–2018 CLHLS Data	7
Sex Difference in the Association between Prior Fracture and Subsequent Risk of Incident Dementia: A Longitudinal Cohort Study	7
Objective and Subjective Measurements of Motor Function: Results from the HELIAD Study	7
Balancing the Conflicting Goals for Treatment of Alzheimer's Disease with Monoclonal Antibodies	7
A Hierarchical Bayesian Latent Class Model for the Diagnostic Performance of Mini-Mental State Examination and Montreal Cognitive Assessment in Screening Mild Cognitive Impairment Due to Alzheimer's D	7
Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition	7
Effects of Non-Invasive Brain Stimulation on Alzheimer's Disease	7

Hypnotics and Incident Dementia: A Risk Assessment	7
Future of Alzheimer's Disease Treatment: Combination Therapy and Precision Medicine	7
Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD)	7
Association of Preeclampsia with Incident Dementia and Alzheimer's Disease among Women in the Framingham Offspring Study	7
Chronic Pain in Multiple Sites and Dementia: A Vicious Cycle?	7
Personalized Computational Causal Modeling of the Alzheimer Disease Biomarker Cascade	7
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging	7
Association between Cerebrospinal Fluid sTREM2 Levels and Depression: The Alzheimer's Disease Neuroimaging Initiative Study	7
Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force Report	6
Content	6
Usability of a Web-Based Registry for Preclinical Alzheimer's Disease: Implications from a Cross-Sectional Online Survey	6
Reevaluating the sleep-dementia link: Methodological gaps and future directions	6
‘Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings	6
The effect of sleep disturbances on the incidence of dementia for varying lag times	6
Cytomegalovirus Infection and Alzheimer's Disease: A Meta-Analysis	6
Mechanisms Underlying Non-Pharmacological Dementia Prevention Strategies: A Translational Perspective	6
Mitochondrial dysfunction as the missing link between circadian syndrome and dementia	6
The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report	6
The Effects of Dual-Task Training on Cognitive and Physical Functions in Older Adults with Cognitive Impairment; A Systematic Review and Meta-Analysis	6
Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review	6
Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities	5
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease	5
Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report	5
Consistency between Treatment Effects on Clinical and Brain Atrophy Outcomes in Alzheimer's Disease Trials	5
Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality	5
The Association between Peanut and Peanut Butter Consumption and Cognitive Function among Community-Dwelling Older Adults	5
Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease	5
Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial	5
The Effect of Multidomain Interventions on Global Cognition, Symptoms of Depression and Apathy — A Pooled Analysis of Two Randomized Controlled Trials	5
Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers	5
On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use	5
Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force	5
Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality	5
The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer's Biomarker Results to Research Participants	5
The Role of Thyroid Dysfunction in Alzheimer's Disease: A Systematic Review and Meta-Analysis	5
15th Conference Clinical Trials Alzheimer's Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer's Disease	5
Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study	5
A Novel Computerized Cognitive Stress Test to Detect Mild Cognitive Impairment	5
Non-Genetic Risk Factors of Alzheimer's Disease: An Updated Umbrella Review	4
Modifiable Risk Factors for Accelerated Decline in Processing Speed: Results from Three Dutch Population Cohorts	4
AMBAR: A Therapeutical Approach for Alzheimer's Disease Patients Regardless of Amyloid Status	4
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial	4
Prevalence Estimation of Dementia/Alzheimer's Disease Using Health and Retirement Study Database in the United States	4
Effects of the COVID-19 Pandemic on the Number of New Dementia Diagnoses and the Quality of Dementia Diagnostics and Treatment	4
Evaluating the Performance of Different Criteria in Diagnosing AD and Preclinical AD with the Bayesian Latent Class Model	4
The Effects of Different Exercise Interventions on Patients with Subjective Cognitive Decline: A Systematic Review and Network Meta-Analysis	4
Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimerʼs disease in a Chinese cohort	4
Associations between Participant Characteristics and Participant Feedback about an Unsupervised Online Cognitive Assessment in a Research Registry	4
Development and Validation the Mobile Toolbox (MTB) Spelling Test	4
Effectiveness of a Meta-Cognitive Group Intervention for Older Adults with Subjective Cognitive Decline or Mild Cognitive Impairment: The ASPIRE Randomized Controlled Trial	4
Leveraging Diverse Regulated Cell Death Patterns to Identify Diagnosis Biomarkers for Alzheimer's Disease	4
Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data	4
LMTK2 and CRB1 are two novel risk genes for Alzheimer's disease in Han Chinese	4
Pushing through the Barriers: Peer Advice to Increase Physical Activity and Reduce Dementia Risk from Participants in a Massive Open Online Alzheimer's Focused Course	4
MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study	4
Psychometric Properties of the Clinical Dementia Rating — Sum of Boxes and other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population	4
Projected Savings to Canadian Provincial Budgets from Reduced Long-Term Care Home Utilization Due to a Disease-Modifying Alzheimer's Treatment	4
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration	4
Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses	4
The Shape Trail Test Is Sensitive in Differentiating Older Adults with Mild Cognitive Impairment: A Culture-neutral Five-minute Test	4
Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease	3
Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention	3
Association of dietary fatty acids with longitudinal change in plasma-based biomarkers of Alzheimer's disease	3
Aducanumab Trials EMERGE But Don't ENGAGE	3
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion	3
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project	3
Association between Comorbidity Indices and Functional Autonomy in Individuals with Cognitive Impairment: A Systematic Review	3
Overtreating Alzheimer's Disease	3
Fish and Shellfish Consumption, Cognitive Health and Mortality from Alzheimer's Disease among US Adults Aged 60 and Older	3
Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults	3
How Larger Society Can Give a Helping Hand to Worldwide FINGERS	3
Examining the Diagnostic Accuracy of a Novel Performance-Based Test for Alzheimer's Disease Screening	3
Blood-Based Biomarkers for Alzheimer's Disease: Are We There Yet?	3
When It Comes to Lecanemab (and Donanemab), How Might We Think about ‘Reasonable and Necessary'?	3
Quantifying Recruitment Source and Participant Communication Preferences for Alzheimer's Disease Prevention Research	3
Periodontal Disease and Alzheimer's: Insights from a Systematic Literature Network Analysis	3
Cohort-Specific Optimization of Models Predicting Preclinical Alzheimer's Disease, to Enhance Screening Performance in the Middle of Preclinical Alzheimer's Disease Clinical Studies	3
Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment	3
Reply to: Enhancing Statin Research for Alzheimer's Prevention: Suggestions for Future Studies and Policy Implications	3
Plasma neurofilament light mediates the effects of Apolipoprotein E on brain atrophy and cognitive decline in the comorbid Alzheimer's disease and cerebral small vessel disease	3

Microstructural white matter injury contributes to cognitive decline: Besides amyloid and tau	3
Informal care for people with dementia in Europe	3
First Experiences with Amyloid-Related Imaging Abnormalities — Yet without Imaging that Can Rule Out Cerebral Injury or Monitor Efficacy of Recommended Management	3
Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats	3
Introduction to the Special Issue on the A4 Study	3
Childhood Secondhand Smoke Exposure and Risk of Dementia in Adulthood	3
What Are the Remaining Challenges before Blood-Based Biomarkers for Alzheimer's Disease Can Be Used in Clinical Practice?	3
Adding the Topographical Information from Tau-PET to the A/T/(N) Framework: Steps Towards Staging AD in Vivo	3
Content	3
Expert opinion on Centiloid thresholds suitable for initiating anti-amyloid therapy. Summary of discussion at the 2024 spring Alzheimer's Association Research Roundtable	3
Cohort Effects in Alzheimer's Disease Trials: An Empirical Assessment Utilizing Data from the Alzheimer's Disease Cooperative Study	3
Association of Multi-Domain Factors with Cognition in the UK Biobank Study	3
Symposia — Oral Communications — Late Breaking News	3
Fructose Consumption is Associated with a Higher Risk of Dementia and Alzheimer's Disease: A Prospective Cohort Study	3
Enhancing dementia prediction: A 19-year validation of the CAIDE risk score with insulin resistance and APOE ε4 integration in a population-based cohort	3
Environmental Distractions during Unsupervised Remote Digital Cognitive Assessment	3
Determinants of Medical Direct Costs of Care among Patients of a Memory Center	3
Posters	3
A Randomized Prospective Survey Targeting Knowledge, Barriers, Facilitators and Readiness to Participation in Dementia Research	3
Study Protocol of a Comprehensive Activity Promotion Program for the Prevention of Dementia: A Randomized Controlled Trial Protocol	3
US Adults' Likelihood to Participate in Dementia Prevention Drug Trials: Results from the National Poll on Healthy Aging	3
Prediction of Alzheimer's Disease Based on 3D Genome Selected circRNA	3
Tau Pathologies Mediate the Associations of Vascular Risk Burden with Cognitive Impairments in Non-demented Elders: The CABLE Study	3
What Is Reasonable and Necessary for Alzheimer Patients from Randomized Clinical Trials to Clinical Practice?	3
The Journal of Prevention of Alzheimer Disease (JPAD) Is Entering Its Second Decade 2014–2024	3
Longitudinal Trajectories of the Cognitive Function Index in the A4 Study	3